Trio of Clinical Trials Supports H1N1 Vaccine’s Effectiveness

Posted by Admin | Posted in Medical Lawyers | Posted on 16-12-2009

A single dose of unadjuvanted vaccine with 7.5 micrograms of antigen is effective against the pandemic influenza A(H1N1) virus for most healthy adults, but children younger than 9 years may need two doses for full protection, data from a trio of clinical trials in China, Hungary, and the United States indicate. The findings were published online in the Lancet on Dec. 16.

IOM Report Advises National Vaccine Plan on Priorities

Posted by Admin | Posted in Medical Lawyers | Posted on 12-12-2009

The National Vaccine Plan should prioritize limited resources to meet unmet health needs and to increase funds for safety research and communication, the Institute of Medicine said in a new report.

Panel Supports Inhaled Antibiotic for Pseudomonas Lung Infection in Cystic Fibrosis

Posted by Admin | Posted in Medical Lawyers | Posted on 11-12-2009

GAITHERSBURG, Md. (EGMN) Studies of an inhaled formulation of the monobactam antibiotic aztreonam in patients with cystic fibrosis show that it is a safe and effective treatment for lung infections in this population, most of a federal advisory panel agreed at a meeting on Dec. 10.

What Is A Medical Malpractice Law Job?

Posted by Admin | Posted in Medical Stuff | Posted on 10-12-2009


Read the rest of this entry »

Mid-November Seasonal Influenza Vaccine Use Stats Similar to Last Year

Posted by Admin | Posted in Medical Lawyers | Posted on 10-12-2009

The existence of novel pandemic influenza A(H1N1) influenza in 2009 does not appear to have influenced the U.S. adult populations acceptance or uptake of seasonal influenza vaccination, according to the results of a survey of a nationally representative sample conducted Nov. 4-16.

Most Practices Too Small for Accurate Performance Assessment

Posted by Admin | Posted in Medical Lawyers | Posted on 09-12-2009

Most primary care practices are not large enough for significant differences in performance to be assessed using national quality and cost benchmarks, according to a report in the Dec. 9 issue of JAMA.

FDA Highlighting Liver Damage Risks with Diclofenac

Posted by Admin | Posted in Medical Lawyers | Posted on 08-12-2009

Bendamustine Outshines CHOP in Indolent Lymphoma

Posted by Admin | Posted in Medical Lawyers | Posted on 07-12-2009

NEW ORLEANS (EGMN) Bendamustine plus rituximab could oust the standard chemotherapy regimen used with rituximab in the first-line treatment of advanced lymphomas.

Safety Warnings Added to Desipramine Label

Posted by Admin | Posted in Medical Lawyers | Posted on 03-12-2009

Warnings related to the risk of sudden death and cardiac dysrhythmias associated with desipramine have been added to the label of the tricyclic antidepressant, according to the Food and Drug Administration.

New Ultrasound Technique May Accurately Identify Skin Cancer

Posted by Admin | Posted in Medical Lawyers | Posted on 02-12-2009

CHICAGO (EGMN) An ultrasound technique that measures tissue elasticity could dramatically alter the way in which skin cancer is diagnosed.